Voltage-operated calcium channels: Characteristics and their role in the mechanism of action of psychotropic drugs

Polish Journal of Pharmacology

Volumn 51, Issue 2, 1999, Pages 179-186

  Antkiewicz Michaluk, Lucyna ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Antidepresants; Dihydropyridines; Morphine analgesia; Morphine dependence; Psychiatric illness; Voltage operated channels

Indexed keywords

CALCIUM CHANNEL; CALCIUM ION; MORPHINE; POTASSIUM CHANNEL; POTASSIUM ION; PSYCHOTROPIC AGENT; SODIUM CHANNEL; SODIUM ION;

CONFERENCE PAPER; DRUG MECHANISM; ELECTROPHYSIOLOGY; MORPHINE ADDICTION; NERVE ENDING;

ANIMALS; CALCIUM CHANNELS; CALCIUM CHANNELS, L-TYPE; HUMANS; ION CHANNEL GATING; MENTAL DISORDERS; MORPHINE DEPENDENCE; PSYCHOTROPIC DRUGS;

EID: 0032945627     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (71)

1. Akaike N., Kostyuk P., Osipchuk Y.: Dihydropyridine-sensitive low-threshold calcium channels in isolated rat hypothalamic neurones. J. Physiol., 1989, 412, 181-1952.
2. Antkiewicz-Michaluk L., Michaluk J., Romańska I., Vetulani J.: Cortical dihydropyridine binding sites and a behavioural syndrome in morphine-abstinent rats. Eur. J. Pharmacol., 1990, 180, 129-135.
3. 3H]-nitrendipine binding sites in cortical and hippocampal membranes. Psychopharmacology, 1990, 101, 240-243.
4. 2+ channel. Eur. J. Pharmacol., 1995, 294, 459-468.
5. Antkiewicz-Michaluk L., Michaluk J., Romańska I., Vetulani J.: Reduction of morphine dependence and potentiation of analgesia by chronic co-administration of nifedipine. Psychopharmacology, 1993, 111, 457-464.
6. Antkiewicz-Michaluk L., Romańska I., Michaluk J., Vetulani J.: Role of calcium channels in effects of anti-depressant drugs in responsiveness to pain. Psychopharmacology, 1991, 105, 269-274.
7. Bean B. P.: Neurotransmitter inhibition of neuronal calcium currents by changes in channel voltage dependence. Nature, 1989, 340, 153-156.
8. Bean B. P.: Gating for the physiologist. Nature, 1990, 348, 192-193.
9. Bean B. P., Sturek M., Puga A., Hermsmeyer K.: Calcium channels in muscle cells isolated from rat mesenteric arteries: modulation by dihydropyridine drugs. Circ. Res., 1986, 59, 229-235.
10. Beauchamp G., Lavoie P., Elie R.: Effect of trimipramine on depolarization-induced 45Ca uptake in synaptosomes from the cortex of the rat brain. Neuropharmacology, 1992, 31, 229-234.
11. Bolger G., Gengo P., Luchowski E., Siegel H., Triggle D., Janis R.: High affinity binding of a calcium channel antagonist to smooth and cardiac muscle. Biochem. Biophys. Res. Commun., 1982, 104, 1604-1609.
12. Bolger G., Weissman B., Bacher J., Isaac L.: Calcium antagonist binding in cat brain tolerant to electroconvulsive shock. Pharmacol. Biochem. Behav., 1987, 27, 217-221.
13. Brennan C., Crabbe J., Littleton J.: Genetic regulation of dihydropyridine-sensitive calcium channels in brain may determine susceptibility to physical dependence on alcohol. Neuropharmacology, 1990, 29, 429-432.
14. Cadet J., Taylor E., Freed W.: The iminodipropionitrile (IDPN)-induced dyskinetic syndrome in mice: antagonism by calcium channel antagonist nifedipine. Pharmacol. Biochem. Behav., 1987, 29, 381-385.
15. Campbell K. P., Leung A. T., Sharp A. H.: The biochemistry and molecular biology of the dihydropyridine sensitive calcium channel. Trends Neurosci., 1988, 11, 425-430.
16. Catterall W. A.: Structure and function of voltage-sensitive ion channels. Science, 1988, 242, 50-61.
17. Chapman D., Way E.: Modification of endorphin/enkephalin analgesia and stress-induced analgesia by divalent cations, a cation chelator and ionophore. Brit. J. Pharmacol., 1982, 75, 389-396.
18. Curtis B. M., Catterall W. A.: Purification of the calcium antagonist receptor of the voltage-sensitive calcium channel from skeletal muscle transverse tubules. Biochemistry, 1984, 23, 2113-2118.
19. Dinan T., Silverstone T., Cookson J.: Cortisol, prolactin and growth hormone levels with clinical ratings in manic patients treated with verapamil. Int. Clin. Psychopharmacol., 1988, 3, 151-156.
20. Dolin S., Little H., Hudspith M., Pagonis C., Littleton J.: Increased dihydropyridine-sensitive calcium channels in rat brain may underlie ethanol physical dependence. Neuropharmacology, 1987, 26, 275-279.
21. Dolin S., Patch T., Rabbani M., Siarey R., Bowhay A., Little H.: Nitrendipine decreases benzodiazepine withdrawal seizures but not the development of benzodiazepine tolerance or withdrawal signs. Brit. J. Pharmacol., 1990, 101, 691-697.
22. Dooley D. J., Lupp A., Hertting G.: Inhibition of central neurotransmitter release by ω-conotoxin GVIA, a peptide modulator of the N-type voltage-sensitive calcium channel. Naunyn-Schmied. Arch. Pharmacol., 1987, 336, 467-470.
23. Dubovsky S.L., Franks R.: Intracellular calcium ions in affective disorders: a review and a hypothesis. Biol. Psychiat., 1983, 18, 781-797.
24. Dubovsky S. L., Franks R., Allen S., Murphy J.: Calcium antagonists in mania: a double-blind study of verapamil. Psychiat. Res., 1986, 18, 309-320.
25. Falk W. E., Wojick J. D., Gelenberg A. J.: Diltiazem for tardive dyskinesia and tardive dystonia. Lancet, 1988, 1, 824-825.
26. Flockerzi V., Oeken H.-J., Hofman F., Pelzer D., Cavalie A., Trautwein W.: Purified dihydropyridine-binding site from skeletal muscle t-tubules is a functional calcium channel. Nature, 1986, 323, 66-68.
27. Giannini A., Houser W., Loiselle R., Giannini M., Price W.: Antimanic effects of verapamil. Amer. J. Psychiat., 1984, 141, 1602-1603.
28. 2+ uptake. J. Pharmacol. Exp. Ther., 1979, 209, 132-136.
29. Harris R. A., Yamamoto H., Loh H., Way E. L.: Discrete changes in brain calcium with morphine analgesia, tolerance-dependence and abstinence. Life Sci., 1977, 20, 501-506.
30. Herdon H., Nahorski S. R.: Investigations of the roles of dihydropyridine and ω-conotoxin-sensitive calcium channels in mediating depolarization-evoked endogenous dopamine release from striatal slices. Naunyn-Schmied. Arch. Pharmacol., 1989, 340, 36-40
31. Hillman D., Chen S., Aung T. T., Cherksey B., Sugimori M., Llinas R. R.: Localization of P-type calcium channels in the central nervous system. Proc. Nat. Acad. Sci. USA, 1991, 88, 7076-7080.
32. Kamikubo K., Niwa M., Fugimura H., Miura K.: Morphine inhibits depolarization-dependent calcium uptake by synaptosomes. Eur. J. Pharmacol., 1983, 95, 149-150.
33. Kavaliers M.: Stimulatory influences of calcium channel antagonists on stress-induced opioid analgesia and locomotor activity. Brain Res., 1987, 408, 403-409.
34. Kushnir S. L., Ratner J. T.: Calcium channel blockers for tardive dyskinesia in geriatric psychiatric patients. Amer. J. Psychiat., 1989, 146, 1218-1219.
35. Llinas R. R., Sugimori M., Cherksey B.: Voltage-dependent calcium conductances in mammalian neurons. The P channel. Ann. NY Acad. Sci., 1989, 560, 103-111.
36. Llinas R. R., Sugimori M., Lin J. W., Cherksey B.: Blocking and isolation of a calcium channel from neurons in mammals and cephalopods utilising a toxin fraction (FTX) from funnel-web spider poison. Proc. Nat. Acad. Sci. USA, 1989, 86, 1689-1693.
37. Maggi C. A., Tramontana M., Cecconi R., Santicioli P.: Neurochemical evidence for the involvement of N-type calcium channels in transmitter secretion from peripheral endings of sensory nerves in guinea pigs. Neurosci. Lett., 1990, 114, 203-206.
38. Mamczarz J., Karolewicz B., Antkiewicz-Michaluk L., Vetulani J.: Co-administration of nifedipine with neuroleptics prevents development of activity changes during withdrawal. Pol. J. Pharmacol., 1994, 46, 75-77.
39. McCormick D. A., Prince D. A.: Noradrenergic modulation of firing pattern in guinea pig and cat thalamic neurons. J. Neurophysiol., 1988, 593, 978-995.
40. McKenna E., Koch W. J., Slish D. F., Schwartz A.: Towards an understanding of the dihydropyridine sensitive calcium channel. Biochem. Pharmacol., 1990, 39, 1145-1150.
41. Messing R., Sneade A., Savidge B.: Protein kinase C participates in up-regulation of dihydropyridine-sensitive calcium channels by ethanol. J. Neurochem., 1990, 55, 1383-1389.
42. Michaluk J., Karolewicz B., Antkiewicz-Michaluk L., Vetulani J.: Effects of various calcium channel antagonists on morphine analgesia, tolerance and dependence, and on blood pressure in the rat. Eur. J. Pharmacol., 1998, 352, 189-197.
43. Mogilnicka E., Czyrak A., Maj J.: Dihydropyridine calcium channel antagonists reduce immobility in the mouse behavioral despair test; antidepressants facilitate nifedipine action. Eur. J. Pharmacol., 1987, 138, 413-416.
44. Mogilnicka E., Czyrak A., Maj J.: BAY K 8644 enhances immobility in the mouse behavioral despair test, an effect blocked by nifedipine. Eur. J. Pharmacol., 1988, 151, 307-311.
45. Mori Y., Friedrich T., Kim M. S., Mikami A., Nakai J. R., Bosse E., Hofmann F., Flockerzi V., Furuichi T., Mikoshiba K., Imoto K., Tanabe T., Numa S.: Primary structure and functional expression from complementary DNA of a brain calcium channel. Nature, 1991, 350, 398-402.
46. Muntaner C., Kumor K., Nagoshi C., Jaffe J.: Effects of nifedipine pretreatment on subjective and cardiovascular responses to intravenous cocaine in humans. Psychopharmacology, 1991, 105, 37-41.
47. North R. A.: Opioid receptors types and membrane ion channels. Trends Neurosci., 1986, 9, 114-117.
48. Nowycky M. C., Fox A. P., Tsien R. W.: Three types of neuronal calcium channel with different calcium agonist sensitivity. Nature, 1985, 316, 440-443.
49. Ogata N., Yoshii M., Narahashi T.: Differential block of sodium and calcium channels by chlorpromazine in mouse neuroblastoma cells. J. Physiol., 1990, 420, 165-183.
50. Olivera B. M., Gray W. R., Zekus R., McIntosh J. M., Varga J., Rivier J., DeSantos V., Cruz L. J.: Peptide neurotoxins from fish-hunting cone snails. Science, 1985, 230, 1338-1343.
51. Owen P. J., Marriott D. B., Boarder M. R.: Evidence for a dihydropyridine-sensitive and conotoxin-insensitive release of noradrenaline and uptake of calcium in adrenal chromaffin cells. Brit. J. Pharmacol., 1989, 97, 133-138.
52. Perez-Reyes E., Wei X., Castellano A., Birnbaumer L.: Molecular diversity of L-type calcium channels. J. Biol. Chem., 1990, 265, 20430-20436.
53. Pin J. P., Bockaret J. W.: Conotoxin GVIA and dihydropyridines discriminate two types of calcium channels involved in GABA release from striatal neurons in culture. Eur. J. Pharmacol., 1990, 188, 81-84.
54. Rabbani M., Little H. J.: Changes in dihydropyridine binding in cerebral cortex following chronic barbital treatment. Brit. J. Pharmacol., 1991, 101, Suppl., 568P.
55. 3H]-nimodipine binding sites in the brain upon chlorpromazine treatment and subsequent withdrawal. Res. Commun. Chem. Path. Pharmacol., 1985, 48, 463-466.
56. Ramkumar V., El-Fakahany E.: Prolonged morphine treatment increases rat brain dihydropyridine binding sites: possible involvement in morphine dependence. Eur. J. Pharmacol., 1988, 146, 73-77.
57. Regan L. J., Sah D. W. Y., Bean B. P: Calcium channel in rat central and peripheral neurons: high-threshold current resistant to dihydropyridine blockers and omega-conotoxin. Neuron, 1991, 6, 269-280.
58. 3H]-5HT-release in rat brain slices. Neurosci. Lett., 1990, 115, 323-328.
59. Ross D. H., Cardenas H. L.: Nerve cell calcium as a messenger for opiate and endorphin actions. In: Adv. Biochem. Psychopharmacol., 1979, Vol. 20, 301-336.
60. Schepelern S., Koster A.: Verapamil in treatment of severe schizophrenia. Acta Psychol. Scand., 1987, 75, 557-558.
61. Shapira S., Kadar T., Adeymo O. M., Feuerstein G.: Selective hippocampal lesion following omega-conotoxin administration in rats. Brain Res., 1990, 523, 291-294.
62. Silverstone P., Grahame-Smith D.: Effects of chronic lithium amitriptyline, and electroconvulsive shock on calcium channel binding in a rat brain homogenate. Psychopharmacology, 1991, 105, 132-133.
63. 45Calcium uptake in synaptosomes and in PC12 cells. Biochem. Pharmacol., 1987, 36, 2227-2229.
64. Takahashi K., Akaike N.: Nicergoline inhibits T-type calcium channels in rat isolated hippocampal CA1 pyramidal neurones. Brit. J. Pharmacol., 1990, 100, 705-710.
65. Tank D.W., Sugimori M., Connor J. A., Llinas R. R.: Spatially resolved calcium dynamics of mammalian Purkinje cells in cerebellar slice. Science, 1988, 242, 773-777.
66. Tsien R. W., Ellinor P. T., Horne W. A.: Molecular diversity of voltage-dependent calcium channels. Trends Pharmacol. Sci., 1991, 12, 349-354.
67. Tsien R. W., Lipscombe D., Madison D. V., Bley K. R., Fox A. P.: Multiple types of neuronal calcium channels and their selective modification. Trends Neurosci., 1988 11, 431-438.
68. Twombly D. A., Herman M. D., Kye C. H., Narahashi T.: Ethanol effects on two types of voltage-activated calcium channels. J. Pharmacol. Exp. Ther., 1990, 254, 1029-1037.
69. Varadi G., Mori Y., Mikala G., Schwartz A.: Molecular determination of calcium channel function and drug action. Trends Pharmacol. Sci., 1995, 16, 43-49.
70. Walden J., Grunze H.: Calcium antagonistic effects of carbamazepine as a mechanism of action in neuropsychiatric disorders: studies in calcium dependent model of epilepsies. Eur. Neuropsychopharmacol., 1992, 2, 455-462.
71. 3H]-acetylcholine from the myenteric plexus, phrenic nerve and neocortex of rats. Naunyn-Schmied. Arch. Pharmacol., 1990, 341, 288-294.